Found 78 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

12 years and younger
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on individuals with infantile-onset Pompe disease (IOPD). Pompe disease is a rare genetic disorder caused by the buildup of a complex sugar called glycogen in the body's cells. This buildup impairs the function of various organs and tissues, especially muscles. The …
18-90 years
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of an investigational medication in adults with chronic pruritus of unknown origin (CPUO). Pruritus is a medical term for severe itching. The study involves two separate treatment arms, where participants will receive either the investigational medication or a placebo. A placebo is an …
18-65 years
All genders
Phase 3
Interventional
This study investigates the effect of an investigational medication on heart health in adults with Fabry disease, a genetic disorder that affects the body's ability to break down a specific type of fat. This can lead to a buildup of fat in the body's cells, causing various symptoms, including heart …
18-75 years
All genders
Phase 2
Interventional
This study investigates the use of an investigational medication for treating adults with moderate-to-severe asthma. Asthma is a condition where the airways in the lungs become inflamed and narrow, making it difficult to breathe. The study aims to understand the long-term safety, tolerability, and effectiveness of this medication in participants …
12 years and older
All genders
Phase 2/3
Interventional
This study investigates the safety and effectiveness of an investigational medication in people with moderate to severe atopic dermatitis, a skin condition that causes itchy and inflamed skin. Participants in this study have previously been involved in a clinical trial for this investigational medication and will continue to be monitored …
18 years and older
All genders
Phase 4
Interventional
This study investigates the effect of an investigational medication compared to standard care in preventing or slowing lung function decline in adults with uncontrolled moderate to severe asthma. Asthma is a condition where the airways in the lungs become inflamed and narrow, making it difficult to breathe. The study aims …
18-80 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication given as an add-on therapy for adults with moderate-to-severe asthma. Asthma is a condition where the airways in the lungs become inflamed and narrow, making it hard to breathe. The study aims to assess how well the medication works, its safety, …
12-35 years
All genders
Phase 2
Interventional
This study investigates the safety and effectiveness of an investigational medication for people with newly diagnosed Type 1 Diabetes (T1D) who are already using insulin. Type 1 Diabetes is a condition where the body does not produce insulin, a hormone needed to allow sugar to enter cells to produce energy. …
40-85 years
All genders
Phase 3
Interventional
This study investigates the safety and tolerability of an investigational medication for individuals with Chronic Obstructive Pulmonary Disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. The study involves participants who have completed previous clinical studies related to this condition. Participants will receive the investigational …
16 years and older
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on pain symptoms in individuals with Fabry disease. Fabry disease is a genetic condition that can cause pain in the nerves and abdomen. Participants in this study must be 16 years or older and have Fabry disease but have not received …